Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Beyeler (Bern, Switzerland), C. Wotzkow (Bern, Switzerland), A. Sengal (Bern, Switzerland), P. Wick (St. Gallen, Switzerland), S. Tschanz (Bern, Switzerland), B. Haenni (Bern, Switzerland), C. Von Garnier (Bern, Switzerland), F. Blank (Bern, Switzerland). Enhanced adverse health effects upon in vivo exposure to multi-walled carbon nanotubes in chronic obstructive pulmonary disease. 4240

Member's Comments

No comment yet.

Related content which might interest you: Exacerbations of occupational chronic obstructive pulmonary disease due to industrial aerosols containing nanoparticles after recovering from COVID-19 Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections Year: 2021 Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Source: Eur Respir J 2007; 30: 1131-1137 Year: 2007 Multi-walled carbon nanotubes elicit sustained pulmonary remodelling depending on gender rather than a functional Nrf2 status Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Monocyte subpopulations, airway inflammation and lung function in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols containing nanoparticles Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020 The impact of airborne occupational exposure in chronic obstructive pulmonary disease Source: Annual Congress 2010 - The impact of airborne occupational exposure in COPD Year: 2010 Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD Source: Eur Respir J 2003; 21: 47S-51S Year: 2003 The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary disease Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Are acute changes in CO2 measurable with transcutaneous technique in patients with very severe chronic obstructive pulmonary disease? Source: International Congress 2015 – COPD: notable points Year: 2015 Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005 Effects of comorbidities on physical activity in chronic obstructive pulmonary disease Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Assessment of low dose effects of acute sulfur dioxide exposure on the airways using non-invasive methods Source: Annual Congress 2008 - Air pollution effects on lung and heart Year: 2008 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 The role of prooxidant effect of metals with variable valiancy in pathogenesis of chronic obstructive diseases of lungs Source: Eur Respir J 2002; 20: Suppl. 38, 96s Year: 2002 Role of inhaled antioxidants in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 The effect of nutrition on the pulmonary functions in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 Endothelial microparticles as markers of exercise capacity in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases Year: 2018 Deposition and effects of fine and ultrafine particles in the respiratory tract Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=77 Year: 2002 Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005